Author Question: A client is to receive darbepoetin alfa (Aranesp) adjunctive medication during chemotherapy. The ... (Read 353 times)

natalie2426

  • Hero Member
  • *****
  • Posts: 524
A client is to receive darbepoetin alfa (Aranesp) adjunctive medication during chemotherapy. The client says, Not another drug. Why do I need this one? How should the nurse respond?
 
  1. I know you are tired of drugs, but this is just one more.
  2. This drug will help you grow red blood cells.
  3. This drug will help keep you from getting infections.
  4. This is an erythropoiesis-stimulating factor.
  5. This drug will help you get more oxygen around to your tissues so you feel better.

Question 2

A client has been treated with an erythropoiesis-stimulating factor. Which client assessment would the nurse interpret as indicating the goal of this treatment has been reached?
 
  1. The client's hemoglobin values have risen.
  2. The client reports less shortness of breath on exertion.
  3. The client has not had an episode of epistaxis in over three weeks.
  4. The client reports enjoying a walk with family for the first time in months.
  5. The client has not had a fever since treatment began.



pikon

  • Sr. Member
  • ****
  • Posts: 361
Answer to Question 1

Correct Answer: 2,5
Rationale 1: This response does not answer the client's question.
Rationale 2: Darbepoetin alfa (Aranesp) is an erythropoiesis-stimulating factor.
Rationale 3: Darbepoetin alfa (Aranesp) does not increase immunity.
Rationale 4: The nurse should explain the medication in terms the client can understand.
Rationale 5: Darbepoetin alfa (Aranesp) stimulates production of red blood cells which carry oxygen. Getting additional oxygen to the tissues helps the client feel better.

Answer to Question 2

Correct Answer: 1,2,4
Rationale 1: The purpose of this therapy is to increase red blood cells which would increase hemoglobin.
Rationale 2: Since the client has more RBCs, more oxygen can be carried to tissues.
Rationale 3: This drug supports RBC production, not platelet production.
Rationale 4: Increase in activity level indicates treatment success.
Rationale 5: This treatment supports red blood cell production, not white blood cell production.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

For a complete list of videos, visit our video library